Tuesday, September 22, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $339.75 +0.23%
MSFT $498.00 -0.72%
GOOGL $351.16 -1.07%
AMZN $254.98 -1.34%
TSLA $378.90 +0.96%
META $736.60 -0.63%
NVDA $228.87 +0.66%
JPM $340.00 -3.42%
BTC $38.11 -0.37%
ETH $26.27 -0.34%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$339.75
▲ 0.23%
MSFT
$498.00
▼ 0.72%
GOOGL
$351.16
▼ 1.07%
AMZN
$254.98
▼ 1.34%
TSLA
$378.90
▲ 0.96%
META
$736.60
▼ 0.63%
NVDA
$228.87
▲ 0.66%
JPM
$340.00
▼ 3.42%

Top Stories

Markets →
Science Daily
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity. Combining two types of drugs reversed many of these changes and sharply slowed tumor growth in preclinical experiments, offering a possible new strategy for aggressive, treatment-resistant disease.
science  Sep 8, 2026
Bloomberg Markets
“The next couple of months are likely to be pretty rocky with only modest gains to be had for the rest of the year,” says Seema Shah, chief global strategist at Principal Asset Management. Shah says a possible series of hikes by the Federal Reserve can provide some resistance for equities. (Source: Bloomberg)
business  Sep 8, 2026
Bloomberg Markets
Brent oil surged toward $100 a barrel after Saudi Arabia halted some energy operations near its border with Yemen due to attacks, highlighting risks to supply from the region. Novartis shares plunge as much as 10%, marking the worst day since 2020, after its del-desiran treatment for a rare muscle-wasting disease failed to meet the primary endpoint in a phase 3 trial. Vontobel said this is another “major pipeline setback.” The Opening Trade has everything you need to know as markets open acros
business  Sep 8, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free